Agree. It's likely to relate to how the "take-or-pay" stipulation in the agreement has been finalized. One way, would be by paying the agreed/negotiated sum; another way would be negotiating better rates on the imported Antigen test, which Atomo rebrands and supplies in OZ.
A more interesting outcome could relate to the current "non-exclusive" rights, which could be amended or renegotiated. This would have the effect of pressing Atomo's antigen competitor Pantonic from the OZ market - noting that Pantonic also uses the very same non-rebranded Access Bio kit. A similar outcome could be achieved by negotiating supply.
Atomo holds a long standing relationship with Access Bio. Whatever way, I am sure maintaining this relationship is front of mind.
- Forums
- ASX - By Stock
- AT1
- Ann: Trading Halt
Ann: Trading Halt, page-12
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
Add AT1 (ASX) to my watchlist
|
|||||
Last
2.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.89M |
Open | High | Low | Value | Volume |
2.7¢ | 2.8¢ | 2.5¢ | $3.866K | 140.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 472951 | 2.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.8¢ | 143054 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 472951 | 0.025 |
2 | 617050 | 0.024 |
3 | 893000 | 0.023 |
7 | 604373 | 0.022 |
4 | 432292 | 0.021 |
Price($) | Vol. | No. |
---|---|---|
0.028 | 143054 | 2 |
0.029 | 452248 | 7 |
0.030 | 430739 | 8 |
0.031 | 196496 | 4 |
0.033 | 367586 | 3 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
AT1 (ASX) Chart |